Subcutaneous implantation of Hunt-Schilling wound chambers in rats induces a wound repair response causing the chamber first to fill with fluid and subsequently with connective tissue. The presence of a type I collagen gel encouraged a more rapid dispersion of cells throughout the chamber but had no effect on the rate of new collagen deposition. Addition of platelet-derived growth factor (PDGF; 50 ng/chamber) to the collagen-filled chambers caused an earlier influx of connective tissue cells, a marked increase in DNA synthesis, and a greater collagen deposition in the chamber during the first 2 wk after implantation. After 3 wk, however, the levels of collagen were similar in PDGFsupplemented and control chambers. Diabetic animals exhibited a decreased rate of repair which was restored to normal by addition of PDGF to the wound chamber. Combinations of PDGF and insulin caused an even more rapid increase in collagen deposition. These results suggest that the levels of various growth factors, particularly PDGF, may be limiting at wound sites and that supplementation of wounds with these factors can accelerate the rate of new tissue formation.
Introduction
The repair ofdamaged tissue occurs through the concerted action of many specialized cell types which invade the wound in an ordered sequence (1) (2) (3) (4) (5) (6) (7) (8) . Recent studies have identified some of the factors, including chemoattractants, attachment factors, and growth factors, which are required for the entry, migration, and proliferation of cells in the wound (6) (7) (8) . It is possible that in areas of extensive trauma, in patients with diseases such as diabetes, and in individuals receiving certain drugs, the production of these factors is not sufficient to maintain normal healing. In such cases, as well as in normal individuals, it may be possible to increase the rate of repair by adding factors directly to the wound site.
The migration of cells into a wound is thought to be determined in large part by the production of chemoattractants, i.e., chemicals that promote the directed movement of responding cells. A variety of such attractants has been described in in vitro tests for certain cells. Inflammatory cells respond to che-moattractants which would be present at wound sites, including complement peptides (9) , platelet-derived peptides (10) (11) (12) , and bacterial products (13) (14) (15) . Endothelial cells are attracted by still other factors that are not yet well characterized (16) . Fibroblastic cells respond to a different set of chemotactic factors, including fibronectin (17, 18) , lymphokines (19) , and platelet-derived growth factor (PDGF)' (20) (21) (22) (23) . PDGF is a basic protein (Mr = 31,000) which is stored in the a-granules of platelets (24) . PDGF has dual activities, being both chemotactic and mitogenic for fibroblastic cells (20) (21) (22) (23) (24) (25) (26) (27) . Other growth factors including epidermal growth factor (EGF), fibroblast growth factor (FGF), and insulin are not active as chemoattractants. The mitogenic action of PDGF is dependent on the presence of growth factors contained in plasma (24, 26, 27) , whereas the chemotactic activity of PDGF is not (21) .
To test the ability ofgrowth factors to stimulate wound repair, we have used a model system employing Hunt-Schilling chambers (HSC) (28, 29) . When (34) . Normal rats had serum glucose levels of 100±20 mg/dl. 90% of all treated rats had serum glucose levels >300 mg/dl. For our studies, we chose only those rats whose serum glucose levels ranged between 350 and 500 mg/dl. Chambers were implanted on the fifth day after streptozotocin injection. In one series, the animals were maintained on intramuscular injections of insulin (Ultralente Iletin I Insulin, 2 U/d, Eli Lilly & Co., Indianapolis, IN). The insulin treatment lowered the serum glucose to <200 mg/dl. Analysis of chamber contents. Animals were sacrificed by CO2 asphyxiation on the indicated days after implantation, and the chambers were removed surgically. A fibrous capsule which formed outside of the chambers was carefully removed by dissection before the processing of the chambers. Chambers from the most anterior site were fixed in phosphate-buffered saline (PBS)/formalin (3.7%) and used for histological studies. The middle pair was extracted with I N NH4OH/0. 1% TX-100 and a sample was hydrolyzed with 6 N HCl for 24 h at 105°C for amino acid analysis. The most caudal pair was used to determine the rate of DNA synthesis as described below.
Histology. The tissue contained in the chambers was stored in PBS/ formalin (3.7%) until samples from all the time points had been collected. The fixed tissue was then removed from the chambers, embedded in paraffin, and six 10-jum sections were cut and stained with hematoxylineosin. The sections were viewed with a Zeiss photomicroscope III (Carl Zeiss, Inc., Thornwood, NY). 10 fields from each data point were observed. Some variation between fields of the same section were seen, although these were not as great as the differences between two experimental groups. Fields that represented the mean of those observed were photographed.
Total collagen content. The contents ofthe chambers were solubilized by extracting each chamber with 5 ml of 1 N NH40H/0.1% TX-100 at 100°C for 2 h. An aliquot of the extract was then hydrolyzed in 6 N HCI at 105'C for 24 h and subjected to amino acid analysis with a Durrum amino acid analyzer (Dionex Corp., Sunnyvale, CA). The amount of hydroxyproline was measured, and the amount of collagen was calculated assuming 100 residues of hydroxyproline per collagen a-chain (35 (Fig. 3) . By day 20, however, the control and PDGF-treated samples had reached similar levels of DNA synthesis. Next, we analyzed the amount of new collagen deposited by quantitating the hydroxyproline content of the chamber. PDGF increased the deposition of collagen on days 5 and 10 over that observed in control chambers (Fig. 4) . However, this difference in collagen deposition was transient, and by day 20, similar amounts of collagen were present in the control and in the PDGF-containing chambers. These results indicate that PDGF enhances the initial proliferation of cells in the chamber (37) . These factors include EGF and insulin. In addition, in vitro studies have shown that PDGF plus additional growth factors are required to stimulate cell division (26, 27 ). Thus, we tested whether the addition of a combination of factors could cause an even faster rate of tissue formation. EGF showed some activity in increasing the rate of collagen deposition when added individually, whereas insulin did not (Table I) . PDGF was much more active than any of the other growth factors. Chambers supplemented with a combination of PDGF and insulin showed marginally higher rates of collagen deposition than PDGF alone, suggesting that there may be sufficient levels of insulin or insulinlike growth factors in wound fluids to support maximal cell proliferation.
Effect ofgrowth factors on repair in streptozotocin-induced + 500 ng/ml * The total collagen deposited was determined as described in Methods. The amount of collagen initially added to the chambers has been subtracted from all values (2 mg/ml; 2.4 mg/chamber). The results are the mean±SD of four separate chambers.
diabetic animals. Diabetic individuals often have impaired healing of wounds or develop chronic ulcers. It is possible that these problems are caused by decreased levels of growth factors present at the wound site. Therefore, we next investigated the effects of PDGF on wound repair in diabetic animals. Hematoxylin-and eosin-stained sections of chamber tissue from the diabetic animals appeared to contain fewer cells than in the normal animals (data not shown). As seen in Fig. 5 , the hydroxyproline content of chambers in diabetic animals was only 50% of that in nondiabetic animals on days 20 and 30. This effect could be reversed by adding PDGF (50 ng/ml) to the chambers. In contrast, the addition of insulin to the chambers had no significant effect on the deposition ofnew collagen in either normal or diabetic animals (Table II ). In addition, daily systemic insulin injections did not restore the rate of collagen deposition even though serum glucose levels were lowered by this treatment (data not shown). However, combinations of PDGF and insulin in the wound chamber stimulated a significantly larger increase in the rate of collagen deposition in the diabetic rats than either factor added alone (Table II) . These data suggest that in diabetic animals both PDGF and insulin or insulinlike growth factors may be present in suboptimal levels for cell replication, whereas only PDGF appears to be limiting in nondiabetic animals.
Discussion
Trauma elicits a rapid, localized response leading to the repair, restoration, and replacement of damaged tissues. The process can be divided into the immediate reaction as blood clots and platelets aggregate, an intermediate period during which cells Figure 5 . Effect of diabetes on collagen deposition in wound chambers. Chambers were implanted in both normal and steptozotocin-induced diabetic rats and the total collagen content was determined by hydroxyproline analysis as described in Methods. Data are expressed as the amount of total collagen present minus that amount present in the initial gel (2 mg/ml; 2.4 mg/chamber). The data are the mean±SD of four separate chambers.
accumulate in the wound, and a long slow process where collagen accumulates and restores the tensile strength of the wound. Considerable evidence suggests that local factors generated by tissue damage or clotting initiate and sustain the repair process (6) (7) (8) . It is our postulate that the penetration of new connective tissue cells into the wound limits the rate of repair, and that this process can be accelerated by supplementing wounds with factors that attract cells into the wound site and increase their proliferation.
The wound response to HSC resembles the response to other wound models with regard to the order in which cells enter the wound, the lag before collagen deposition, the rate and kinds of collagen deposited, and the appearance of new blood vessels (28, 29) . However, this model is quite distinct from linear incisions and full thickness skin wounds as there is, for example, no epithelialization. In sum, the stainless steel mesh chamber represents a convenient model for studying quantitative aspects of wound healing, although it is possible that it differs in critical ways from the response elicited in other wound models.
Various mitogens including EGF, FGF, PDGF, and insulin were added to the chambers and their effect on wound healing was determined. Particular attention was directed toward the PDGF because it acts as a potent chemoattractant and mitogen for fibroblastic cells (20) (21) (22) (23) (24) (25) (26) (27) . As little as 50 ng/ml of PDGF caused as much as a twofold increase in collagen deposition and a substantial stimulation of cell proliferation 10 d post implantation. Interestingly, at 20 d, the nonsupplemented chambers approached the levels of collagen deposition and of DNA synthesis observed in the treated chambers. This suggests that a single addition of PDGF accelerates the wound repair response but does not cause a hypertrophic response. This is most probably due to the diffusion of PDGF from the chambers after the first 5-10 d.
Other growth factors were tested for their ability to stimulate collagen deposition in the wound chamber. EGF and FGF showed some enhancement of collagen deposition over nonsupplemented chambers, whereas insulin did not. N-formylmethionyl-leucine-phenylalanine, a potent chemotactic factor for phagocytic cells (13) , did not influence the deposition of collagen (unpublished observations). Combinations ofthe growth factors, particularly PDGF and insulin, showed a somewhat greater response than PDGF alone. This is expected as PDGF is not able to stimulate cell proliferation alone and requires progression factors such as insulin or the somatomedins to complete cellular replication (26, 27) . Because the effects of insulin and EGF were minimal, it is likely that they are not limiting in the wounds of normal animals, or that the chemotactic activity of PDGF is more important than its mitogenic activity in this system.
The wound repair response was considerably reduced in diabetic animals and returned to near that of the nonsupplemented chambers in normal animals by local supplementation of PDGF. Systemic injections of insulin lowered serum glucose levels in diabetic animals but did not restore wound healing to normal; this was possibly because local levels of insulin are not sufficiently high or are not maintained. Addition of insulin alone to the chambers had no effect on blood glucose levels or on the rate of new tissue formation within the chamber. However, combinations of PDGF and insulin stimulated a greater deposition of new collagen than either growth factor added alone. These results suggest that combinations of PDGF and insulin, when added locally to wounds in diabetics, may increase the rate of repair of injured tissue. Presently it is not clear whether the levels of these factors are lower in diabetic animals or if the diabetic state makes the cells less responsive to PDGF. Because diabetics have poor peripheral circulation, the blood supply present at the time of wounding could deliver decreased levels of PDGF and other factors to the wound site.
In summary, it appears that the rate of repair in normal animals is not maximal and may be limited in part by the levels of chemoattractants and growth factors present at the wound site. It is probable that both the penetration of cells into the wound and their subsequent proliferation are rate-limiting events which must occur before the deposition of new collagen and the extracellular matrix. Addition of factors, such as chemoattractants and mitogens for connective tissue cells, could stimulate the overall rate of repair by accelerating the influx of these cells into the wound site. This may be of particular importance in individuals who have poor wound healing, such as diabetics.
